Samsung Display Co., Ltd.

Kolon Life Science, Inc.

Kolon Tissuegene, Inc.

Daewook Kim

Seungin Baek

Jewon Yoo

Sujeong Kim

JaeBum Cho

Hyung Uk Cho

Hyunjin Son

Heonsik Choi

Kyoungbaek Choi

Hyeonyoul Lee

Min Soo Kim

Minjung Kim

Hyesun Lee

Joonsung Kim

Sang-Gu Lee

Sanggu Lee

Minju Kim

Sujin Choi

Eunkyung Koh

Sang-gu Lee

Byongug Park

Jangjoon Park

Soondong Lee

Jongho Cho

Min Kim

Yejin Kwon

Yeomoon Sim

A display device includes: a display panel including a first display area having a first light transmittance and a second display area having a second light transmittance that is higher than the first light transmittance; a camera module under the second display area that is configured to output a raw image signal; a compensation module configured to: activate in response to a compensation control signal; receive the raw image signal; and compensate the raw image signal through a compensation program utilizing a learning data-based deep learning algorithm to generate a compensation image signal; and a control module configured to control operations of the display panel, the camera module, and the compensation module.

Display device and method of driving the same

A method for driving an electronic device may include receiving light passing through a display panel, generating an image signal based on the light, compensating the image signal with a compensation algorithm to generate a compensated image signal, wherein the compensation algorithm is trained with training data including a first comparison image and a second comparison image, and displaying, on the display panel, a compensated image based on the compensated image signal, wherein the first comparison image is a target restoration image and the second comparison image is a composite image.

Electronic device that compensates for light passing through a display

A display device includes pixel circuits disposed on a substrate, each of the pixel circuits comprising a transistor and a storage capacitor, display elements electrically connected to the pixel circuits, and a metal layer disposed between the substrate and the pixel circuits, the metal layer comprising through-holes, wherein the through-holes of the metal layer include a first through-hole, and a second through-hole disposed adjacent to the first through-hole.

Display device and electronic apparatus

Electronic device that compensates for light passing through a display, and driving method for the same

The present invention relates to: a composition for alleviating or treating pain, the composition comprising glutamate decarboxylase and a gene coding for an anti-inflammatory cytokine; and a method for alleviating or treating pain by using the composition.

Composition for treating pain

A display device includes a display module; and a layer disposed on the display module and having a first area and a second area adjacent to the first area, the layer in the first area including a plurality of discontinuities spaced apart from each other. A sum of widths of the plurality of discontinuities is less than about 0.23 times of a width of the first area, each of the widths of the plurality of discontinuities is equal to or less than about 400 &#x3bc;m, and the widths of the plurality of discontinuities and the width of the first area are parallel to a first direction.

Display device

Provided is a cell therapeutic agent for treating an inflammatory disease induced by a hyperimmune response, more specifically, a composition for treating an inflammatory disease induced by a hyperimmune response, which comprises (i) a chondrocyte or a cell capable of differentiating into a chondrocyte; and (ii) a cell into which a gene encoding TGF-&#x3b2; is introduced, wherein the cell in (ii) is derived from human embryonic kidney 293 (HEK-293) cell.

Composition for treating inflammatory disease induced by hyperimmune response

A method for delivery of a therapeutic agent to a nervous tissue. In particular, a method of delivering a therapeutic agent to a nervous tissue protected by the brain-blood barrier or meninges is disclosed. The method for delivery allows delivery of a therapeutic agent to a nervous tissue with high efficiency. In addition, the delivery method of a therapeutic agent to a nervous tissue is safe since it has lower side effects such as nervous damage than a method of administering a therapeutic agent directly to a nervous tissue.

Method for delivery of biological molecule to nervous tissue

Growing community of inventors

Yongin-si, South Korea

Daewook Kim